MBNL1 and breast carcinoma: Furthermore, T[41]a, downregulated by 25-hydroxyvitamin D, 25(OH)D, promotes breast cancer progression by interfering with MBNL1 (muscleblind-like splicing regulator 1)-mediated RNA splicing and JNK pathway regulation.